| Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
|---|---|---|---|---|---|---|---|
| Ganciclovir | 5.00 | High level resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. (May 1997) | |
| Maribavir | 0.73 | No resistance | Laboratory strain, Clinical Isolate | Recombinant | Details | Antiviral susceptibilities and analysis of UL97 and DNA polymerase sequences of clinical cytomegalovirus isolates from immunocompromised patients. (May 1997) |
| Mutant | Resistances |
|---|---|
| A594E |
Ganciclovir:
|
| A594G |
Ganciclovir:
|
| A594P |
Ganciclovir:
|
| A594P |
Maribavir:
|
| A594S |
Ganciclovir:
|
| A594V |
Filociclovir:
|
| A594V |
Maribavir:
|
| A594V |
Ganciclovir:
|